top of page
![](https://static.wixstatic.com/media/d056cc_0cb0b0efbd2748c3934630826d40e598~mv2.jpg/v1/fill/w_789,h_321,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/d056cc_0cb0b0efbd2748c3934630826d40e598~mv2.jpg)
How does Q-actin Work in the Body?
Studies show that Q-actin reduced LPS-induced pro-inflammatory cytokine tumour necrosis factor alpha (TNFα) in both ex vivo human serum and THP-1 cells. TNFα can drive degenerative changes such as in joints when chronically elevated. Research shows that ido-BR1 works in a dose-dependent manner to reduce inflammatory markers, including LPS-induced production of TNFα, IL-6, nitric oxide and the transcription factor NF-κB.
![Graph showing decline in Tumor Necrosis Factor alpha](https://static.wixstatic.com/media/d056cc_7fcc2c696cf34f60823b01ad2033d583~mv2.png/v1/fill/w_340,h_422,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/d056cc_7fcc2c696cf34f60823b01ad2033d583~mv2.png)
bottom of page